Patients with kidney disease should consult their healthcare provider before taking magnesium supplements
When switching from semaglutide to tirzepatide, it is best to stop semaglutide and initiate tirzepatide at a low dose, typically 2.5 mg weekly, regardless of the semaglutide dose
You should discuss your current dose of compounded tirzepatide with your provider
With respect to possible enforcement of this policy, in FDAs press release FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize issued on October 2, FDA stated: FDA reminds compounders of the legal restrictions on making copies of FDA-approved drugs. This language suggests that FDA, in conjunction of with state Boards of Pharmacy may pursue enforcement action against compounders that continue to compound with this ingredient and possibly related combinations outside of the guidance and exemptions noted above
The side effects that felt overwhelming after the first 7.5 mg dose typically become much more manageable by the third or fourth injection
Tirzepatide achieves substantial blood sugar reductions
